COMPARATIVE STUDY OF THE EFFECT OF VARIOUS-FREQUENCY TRANSCRANIAL MAGNETIC STIMULATION ON REPARATIVE PROCESSES IN NEUROPATHY OF THE VII PAIR OF CRANIAL NERVES (LITERATURE REVIEW)
Keywords:
Parkinson's disease, Parkinsonism, clinical and neurological diagnostics, neuroimaging, magnetic resonance imagingAbstract
Facial nerve neuropathy remains one of the most pressing problems in neurology and otolaryngology, despite significant achievements in the development of diagnostic and treatment methods. According to WHO data, the incidence of Bell's paralysis is 15-40 cases per 100,000 population per year, making this disease one of the most common peripheral nerve lesions. The pathological process is characterized by an acute onset, rapid development of symptoms, and the possibility of forming persistent functional disorders in 20-30% of cases, including incomplete restoration of facial muscles, synkinesis, and contracture.
References
Goetz C.G., Tilley B.C., Shaftman S.R., et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results // Movement Disorders. – 2008. – Vol. 23, N
– P. 2129-2170.
Hughes A.J., Daniel S.E., Ben-Shlomo Y., Lees A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service // Brain. – 2002. – Vol. 125, N 4. – P. 861-870.
Postuma R.B., Berg D., Stern M., et al. MDS clinical diagnostic criteria for Parkinson's disease // Movement Disorders. – 2015. – Vol. 30, N 12. – P. 1591-1601.
Scherfler C., Schwarz J., Antonini A., et al. Diagnostic accuracy of dopamine transporter SPECT in Parkinson disease // Movement Disorders. – 2012. – Vol. 27, N 6. – P. 703-714.
Kägi G., Bhatia K.P., Tolosa E. The role of DAT-SPECT in movement disorders // Journal of Neurology, Neurosurgery & Psychiatry. – 2010. – Vol. 81, N 1. – P. 5-12.
Hilker R., Schweitzer K., Coburger S., et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa and D2 receptor binding // Archives of Neurology. – 2005. – Vol. 62, N 3. – P. 378-382.
Vaillancourt D.E., Spraker M.B., Prodoehl J., et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease // Neurology. – 2009. – Vol. 72, N 16. – P. 1378-1384.
Barbosa E.R., Hoexter M.Q., Diniz P.R., et al. Neuroimaging of Parkinson's disease: current use and future perspectives // Arquivos de Neuro-Psiquiatria. – 2015. – Vol. 73, N 6. – P. 529-539.
Salat D.H., Lee S.Y., Seth A.K., et al. The declining inflection of age-related grey matter volume // Neurobiology of Aging. – 2011. – Vol. 32, N 2. – P. 318-330.
Pellecchia M.T., Picillo M., Garavini A., et al. Clinical and neuroimaging features related to levodopa-induced dyskinesias in Parkinson's disease // Movement Disorders. – 2013. – Vol. 28, N 9. – P. 1199-1203.
